Guangzhou Baiyunshan Pharmaceutical Holdings
600332.SS
#2705
Rank
NZ$10.16 B
Marketcap
NZ$6.25
Share price
-0.40%
Change (1 day)
0.58%
Change (1 year)

Operating Margin for Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SS)

Operating Margin as of March 2026 (TTM): 4.57%

According to Guangzhou Baiyunshan Pharmaceutical Holdings's latest financial reports and stock price the company's current Operating Margin is 4.57%. At the end of 2024 the company had an Operating Margin of 4.81%.

Operating Margin history for Guangzhou Baiyunshan Pharmaceutical Holdings from 2002 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
20244.81%-28.92%
20236.77%-5.01%
20227.12%4.1%
20216.84%12.88%
20206.06%-4.62%
20196.36%-33.2%
20189.52%-20.02%
201711.90%22.55%
20169.71%14.03%
20158.51%9.13%
20147.80%11.75%
20136.98%-4.43%
20127.30%18.6%
20116.16%-14.03%
20107.16%20.2%
20095.96%3.97%
20085.73%47.11%
20073.90%5.24%
20063.70%8.94%
20053.40%56.26%
20042.17%-46.75%
20034.08%-15.56%
20024.84%-0.8%
20014.88%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.